Françoise Brunner-Ferber - Brunner Naga, Pfaeffikon Zürich Switzerland

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

An Innovative Ethosuximide Granule Formulation Designed for Pediatric Use: Comparative Pharmacokinetics, Safety, Tolerability, and Palatability Profile Versus Reference Syrup

Leonore Diezi,Kim Dao,Vincent Jullien,Caroline Roussel-Maupetit,Ingrid Burton,Pascal Andre,Carine Bardinet,Laura E. Rothuizen,Haithem Chtioui,Maria A. Manso-Silvan,Catherine Guittet,Francoise Brunner-Ferber,Francois Vandenhende, Catherine Chiron,Luc-Andre Granier,Thierry Buclin

PHARMACOLOGY RESEARCH & PERSPECTIVESno. 1 (2023)

引用1浏览0WOS引用

Trastuzumab Versus MYL-1401O (a Proposed Trastuzumab Biosimilar) in a Phase I Bioequivalence Study: in Vivo and in Vitro Immunomodulation

Ra Agine Audran,Haithem Chtioui,Anne-Christine Thierry,Carole Mayor,Laure Vallotton,Kim Dao,Laura Rothuizen, Ali Maghraoui,Eduardo J. Pennella,Francoise Brunner-Ferber,Thierry Buclin,Francois Spertini

Journal of clinical oncology（2017）

引用0浏览0引用

Biases Affecting Injected Doses of an Experimental Drug During Clinical Trials

Nancy Perrottet,Françoise Brunner-Ferber,Eric Grouzmann,François Spertini,Jérôme Biollaz,Thierry Buclin,Nicolas Widmer

Trials（2016）

引用0浏览0WOS引用

Blocking the Bradykinin Response: Pharmacodynamics and Safety of Icatibant, a Potent and Selective Bradykinin B2 Receptor Antagonist

Judith Zimmermann,Bernd Rosenkranz,Françoise Brunner‐Ferber,Jochen Knolle

Molecular immunologyno. 16 (2008): 4157-4157

引用0浏览0引用

Blocking the bradykinin response: Pharmacodynamics and safety of icatibant, a potent and selective bradykinin B2 receptor antagonist

Jens Zimmermann,Bernd Rosenkranz,Françoise Brunner-Ferber,Jochen Knolle

MOLECULAR IMMUNOLOGY（2008）

引用0浏览0EI引用

Icatibant Has No Impact On Renal Function In Healthy Subjects

Philippe Rousso, Minh Nguyen,Y Perrin,Thierry Buclin,Laurent A Decosterd,Juerg Nussberger,M Appenzeller,F Jaquet,Francoise Brunnerferber,Bernd Rosenkranz,Jochen Knolle,J Biollaz

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 2 (2004): P57-P57

引用1浏览0引用

Pharmacokinetic and Pharmacodynamic Profile of Icatibant

Y Perrin,MT Nguyen,P Rousso,T Buclin,B Rochat,L Decosterd,M Appenzeller,F Jaquet,F Brunner-Ferber,B Rosenkranz,J Knolle,J Biollaz

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 2 (2004): P56-P56

引用3浏览0引用

The Bradykinin Antagonist Icatibant Increases Electrolyte And Water Excretion After Sodium Challenge In Patients With Liver Cirrhosis

Stefan Russmann,Laurent A Decosterd,Thierry Buclin, T Schwaar,Sabine W Baumann,Francoise Brunnerferber,Bernd Rosenkranz,Jochen Knolle,Jurg Reichen

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 2 (2004): P12-P12

引用1浏览0引用

Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjects

Thierry Buclin,Jérôme Biollaz,Erik A Lippa,Françoise Brunner-Ferber, Guy van Melle,Alain Munafo,Coleen Clineschmidt, Jean-Louis Schelling

Clinical Pharmacology and Therapeuticsno. 6 (1991)

引用16浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn